Replimune (REPL) Short-term Investments (2018 - 2026)
Replimune (REPL) reported Short-term Investments of $9.97 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 96.7% from $305.97 million a year earlier and down 83.3% from the prior quarter.
Replimune (REPL) Short-term Investments (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune posted Short-term Investments of $59.87 million, down 83.9% from FY2025.
- Short-term Investments has a five-year compound annual growth rate of -27.3% (FY2021 to FY2026).
- By fiscal year, Short-term Investments came in at $372.69 million in FY2025 (+7.6%), $346.21 million in FY2024 (-20.7%), $436.8 million in FY2023 (+50.8%) and $289.71 million in FY2022 (-1.4%).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Short-term Investments in data going back to fiscal Q4 2018.
- Year over year, Short-term Investments has now declined in each of the last five quarters, with an average decline of 36.6% over the last eight quarters.
- The high point for year-over-year Short-term Investments in five years was fiscal Q3 2022 (growth of 70.6%); the low point was fiscal Q1 2027 (a decline of 96.7%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $59.87 million (Q4 2026), $146.19 million (Q3 2026) and $221.35 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Replimune | 1.15 Bn | 89.88 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.97 Mn |
| Mar 31, 2026 | 59.87 Mn |
| Dec 31, 2025 | 146.19 Mn |
| Sep 30, 2025 | 221.35 Mn |
| Jun 30, 2025 | 305.97 Mn |
| Mar 31, 2025 | 372.69 Mn |
| Dec 31, 2024 | 364.29 Mn |
| Sep 30, 2024 | 318.57 Mn |
| Jun 30, 2024 | 317.47 Mn |
| Mar 31, 2024 | 346.21 Mn |
| Dec 31, 2023 | 368.68 Mn |
| Sep 30, 2023 | 420.77 Mn |
| Jun 30, 2023 | 432.62 Mn |
| Mar 31, 2023 | 436.80 Mn |
| Dec 31, 2022 | 409.71 Mn |
| Sep 30, 2022 | 282.89 Mn |
| Jun 30, 2022 | 282.84 Mn |
| Mar 31, 2022 | 289.71 Mn |
| Dec 31, 2021 | 287.90 Mn |
| Sep 30, 2021 | 275.80 Mn |
Replimune Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=REPL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();